Results 1 to 10 of about 5,286 (232)
Regulatory phosphorylation of Ikaros by Bruton's tyrosine kinase. [PDF]
PLoS ONE, 2013 Diminished Ikaros function has been implicated in the pathogenesis of acute lymphoblastic leukemia (ALL), the most common form of childhood cancer. Therefore, a stringent regulation of Ikaros is of paramount importance for normal lymphocyte ontogeny ...
Hong Ma +5 more
doaj +5 more sources
Role of Bruton’s tyrosine kinase in B cells and malignancies [PDF]
Molecular Cancer, 2018 Bruton’s tyrosine kinase (BTK) is a non-receptor kinase that plays a crucial role in oncogenic signaling that is critical for proliferation and survival of leukemic cells in many B cell malignancies. BTK was initially shown to be defective in the primary
Simar Pal Singh +2 more
doaj +5 more sources
PLoS ONE, 2023 Rheumatoid arthritis is an inflammatory autoimmune disease, characterized by autoantibody production, synovial inflammation, and joint destruction. Its pathogenesis is due to environmental factors and genetic backgrounds.
Daichi Akasaka +9 more
doaj +3 more sources
Targeting Bruton’s Tyrosine Kinase in CLL [PDF]
Frontiers in Immunology, 2021 Targeting the B-cell receptor signaling pathway through BTK inhibition proved to be effective for the treatment of chronic lymphocytic leukemia (CLL) and other B-cell lymphomas.
Inhye E. Ahn, Jennifer R. Brown
doaj +3 more sources
Bruton’s Tyrosine Kinase and Its Isoforms in Cancer [PDF]
Frontiers in Cell and Developmental Biology, 2021 Bruton’s tyrosine kinase (BTK) is a soluble tyrosine kinase with central roles in the development, maturation, and signaling of B cells. BTK has been found to regulate cell proliferation, survival, and migration in various B-cell malignancies.
Xianhui Wang +3 more
doaj +3 more sources
Frontiers in Pharmacology, 2022 Hyperactivation of Bruton’s tyrosine kinase (BTK) or interleukin-2-inducible T cell kinase (ITK) has been attributed to the pathogenesis of B-cell lymphoma or T-cell leukemia, respectively, which suggests that Bruton’s tyrosine kinase and interleukin-2 ...
Peiran Song +21 more
doaj +1 more source
Heliyon, 2023 Bruton's tyrosine kinase (BTK) is a protein involved in B-cell-receptor signaling and B-cell proliferation. The pathophysiology of several autoimmune diseases, such as pemphigus disorder, relies on the BTK signaling pathway.
Yekta Ghane +4 more
doaj +1 more source
Bruton’s Tyrosine Kinase Targeting in Multiple Myeloma [PDF]
International Journal of Molecular Sciences, 2021 Multiple myeloma (MM), a clonal plasma cell disorder, disrupts the bones’ hematopoiesis and microenvironment homeostasis and ability to mediate an immune response against malignant clones. Despite prominent survival improvement with newer treatment modalities since the 2000s, MM is still considered a non-curable disease.
Max Von Suskil +10 more
openaire +3 more sources
eLife, 2021 A combination of X-ray crystallography, NMR, and mass spectrometry has revealed how diverse small-molecule inhibitors bind Bruton’s tyrosine kinase and alter the conformation of this enzyme.
Ganesh Srinivasan Anand
doaj +1 more source
Reining in BTK: Interdomain Interactions and Their Importance in the Regulatory Control of BTK
Frontiers in Cell and Developmental Biology, 2021 Since Dr. Ogden Bruton’s 1952 paper describing the first human primary immunodeficiency disease, the peripheral membrane binding signaling protein, aptly named Bruton’s tyrosine kinase (BTK), has been the target of intense study. Dr. Bruton’s description
Lauren E. Kueffer +2 more
doaj +1 more source